Globe Life (GL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Globe Life Inc. (GL) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for Globe Life (GL) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Globe Life (GL) came out with quarterly earnings of $3.39 per share, missing the Zacks Consensus Estimate of $3.44 per share. This compares to earnings of $3.14 per share a year ago.
Globe Life is set to grow on growing premiums, rising investment income and disciplined capital deployment.
Investors need to pay close attention to Globe Life stock based on the movements in the options market lately.
Globe Life (GL) reported earnings 30 days ago. What's next for the stock?
Globe Life is set to grow on growing premiums, rising investment income, and disciplined capital deployment.
While the top- and bottom-line numbers for Globe Life (GL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Globe Life (GL) came out with quarterly earnings of $4.81 per share, beating the Zacks Consensus Estimate of $4.54 per share. This compares to earnings of $3.49 per share a year ago.
Globe Life offers a mix of life and health insurance products, with growth recently centered around health insurance. Q2 2025 results were solid on both a GAAP and operating income basis, prompting the company to increase its full-year guidance. Globe Life's common stock remains attractively valued, with the shares trading at just 9.3x its 2026 consensus operating earnings.
Globe Life (GL) reported earnings 30 days ago. What's next for the stock?